Qiagen Licenses Biomarker IP from Johns Hopkins

The company plans to use the PI3K gene to develop companion diagnostics for cancer drugs.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories